REFERENCES
1. Hui DS, Azhar IE , Madani TA, et al. The continuing 2019-nCoV
epidemic threat of novel coronaviruses to global health - The latest
2019 novel coronavirus outbreak in Wuhan, China. Int J Infect
Dis . 2020;91:264-6.
2. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical
characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: a descriptive study. Lancet.2020;395(10223):507-13.
3. Huang C, Wang Y, Li X, et al. Clinical features of patients infected
with 2019 novel coronavirus in Wuhan, China. Lancet.2020;395(10223):497-506.
4. She J, Liu L, Liu W. COVID-19 epidemic: Disease characteristics in
children. J Med Virol. 2020. Mar 31.doi: 10.1002/jmv.25807
5. Molloy EJ, Bearer CF. COVID-19 in children and altered inflammatory
responses. Pediatr Res. 2020.
doi: 10.1038/s41390-020-0881-y
6. Yuen KS, Ye ZW, Fung SY, et al. SARS-CoV-2 and COVID-19: The most
important research questions. Cell Biosci . 2020;10:40.
7. Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in
patients with COVID-19 infection. Am J Hematol. 2020.
doi: 10.1002/ajh.25774
8. Henry BM, de Oliveira MHS, Benoit S, et al. Hematologic, biochemical
and immune biomarker abnormalities associated with severe illness and
mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.Clin Chem Lab Med . 2020.
doi: 10.1515/cclm-2020-0369
9. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with
severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.Clin Chim Acta . 2020;506:145-8.
10. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140
patients infected with SARS-CoV-2 in Wuhan, China. Allergy . 2020.
doi: 10.1111/all.14238
11. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus
Disease 2019 in China. N Engl J Med. 2020.
doi: 10.1056/NEJMoa2002032
12. Wang F, Nie J, Wang H, et al. Characteristics of peripheral
lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis .
2020.
doi: 10.1093/infdis/jiaa150
13. Mo P, Xing Y, Xiao Y, et al. Clinical characteristics of refractory
COVID-19 pneumonia in Wuhan, China. Clin Infect Dis . 2020.
doi: 10.1093/cid/ciaa270
14. Xu Y, Li X, Zhu B, et al. Characteristics of pediatric SARS-CoV-2
infection and potential evidence for persistent fecal viral shedding.Nat Med . 2020; 26:502-5.
15. Zini G, Bellesi S, Ramundo F, et al. Morphological anomalies of
circulating blood cells in COVID-19. Am J Hematol. 2020.
doi: 10.1002/ajh.25824
16. Walkovich KL, Newburger PE. Leukopenia. In: Kliegman RM, Stanton BF,
St Geme III JW, Schor NF, Behrman RE eds. Nelson Textbook of
Pediatrics , 20th ed. International Edition: Elsevier; 2016: 1047-1055.
17. Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due
to COVID-19 based on an analysis of data of 150 patients from Wuhan,
China. Intensive Care Med. 2020.
doi: 10.1007/s00134-020-05991-x
18. Barbara J. Bain BJ. Blood Cells .5th ed.
Wiley Blackwell; 2015.
19. Mitra A, Dwyre DM, Schivo M, et al. Leukoerythroblastic reaction in
a patient with COVID-19 infection. Am J Hematol. 2020.
doi: 10.1002/ajh.25793
20. Shi X, Zheng Y, Xu L, Cao C, Dong B, Chen X. The inflammatory
cytokine profile of myelodysplastic syndromes: A meta-analysis.Medicine (Baltimore) . 2019;98:e15844.